Commonwealth Biotechnologies

Commonwealth Biotechnologies is a company that provides R&D services to biotechnology firms, aiming to offer fee-based complex R&D support services to the global biotechnology and pharmaceutical industries. It is a professional life sciences outsourcing enterprise that, through its subsidiaries, provides a set of discovery and development services as well as chemical and biological products, including CBI Services, Fairfax Identity Labs (FIL), and Mimotopes Pty Limited (Mimotopes). Since 2004, CBI has pursued a strategy of acquiring or merging with complementary companies to expand its drug discovery capabilities and profit potential.